Skip to main content
. 2024 Jan 29;11(3):ofae010. doi: 10.1093/ofid/ofae010

Figure 2.

Figure 2.

Mean concentrations of itraconazole and hydroxyitraconazole in patients infected by dimorphic fungi. Super-bioavailability itraconazole (SUBA-itra) demonstrated bioequivalence with conventional itraconazole (c-itra) with respect to both itraconazole and hydroxyitraconazole levels on days 0–42.